Innate immune recognition in tuberculosis infection

Advances in Experimental Medicine and Biology

Volumn 653, Issue , 2009, Pages 185-197

  Tsolaki, Anthony G ^a  

^a BRUNEL UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CHEMOKINE RECEPTOR CCR2; COMPLEMENT RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 23; INTERLEUKIN 27; MANNOSE RECEPTOR; SCAVENGER RECEPTOR; SURFACTANT PROTEIN A; SURFACTANT PROTEIN D; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA; CELL SURFACE RECEPTOR; CYTOKINE; LECTIN; MANNOSE BINDING LECTIN;

ADAPTIVE IMMUNITY; ANTIGEN RECOGNITION; ARTICLE; BACTERIAL SURVIVAL; CELL FUNCTION; CYTOKINE RESPONSE; DENDRITIC CELL; HUMAN; INNATE IMMUNITY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHAGOCYTOSIS; PHAGOSOME; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INTERACTION; TUBERCULOSIS; ANIMAL; HOST PATHOGEN INTERACTION; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; REVIEW;

MYCOBACTERIUM TUBERCULOSIS;

ANIMALS; CYTOKINES; DENDRITIC CELLS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; LECTINS, C-TYPE; MANNOSE-BINDING LECTINS; MYCOBACTERIUM TUBERCULOSIS; PHAGOCYTOSIS; PHAGOSOMES; RECEPTORS, CELL SURFACE; RECEPTORS, COMPLEMENT; RECEPTORS, SCAVENGER; TOLL-LIKE RECEPTORS; TUBERCULOSIS;

EID: 70350500674     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-0901-5_13     Document Type: Article

References (80)

1. Dye C, Scheele S, Dolin P et al. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 1999; 282(7):677-86.
2. Russell DG. Mycobacterium tuberculosis: here today, and here tomorrow. Nat Rev Mol Cell Biol 2001; 2(8):569-77. (Pubitemid 33674008)
3. Kishore U, Bernal AL, Kamran MF et al. Surfactant proteins SP-A and SP-D in human health and disease. Arch Immunol Ther Exp (Warsz) 2005; 53(5):399-417. (Pubitemid 43116640)
4. Tsolaki AG, Hirsh AE, DeRiemer K et al. Functional and evolutionary genomics of Mycobacterium tuberculosis: insights from genomic deletions in 100 strains. Proc Natl Acad Sci USA 2004; 101(14):4865-70. (Pubitemid 38469169)
5. Caws M, Thwaites G, Dunstan S et al. The influence of host and bacterial genotype on the development of disseminated disease with Mycobacterium tuberculosis. PLoS Pathog 2008; 4(3):el000034.
6. Tsolaki AG, Gagneux S, Pyrn AS et al. Genomic deletions classify the Beijing/W strains as a distinct genetic lineage of Mycobacterium tuberculosis. J Clin Microbiol 2005; 43(7):3185-91. (Pubitemid 40981321)
7. Schlesinger LS, Bellinger-Kawahara CG, Payne NR et al. Phagocytosis of Mycobacterium tuberculosis is mediated by human monocyte complement receptors and complement component C3. J Immunol 1990; 144(7):2771-80. (Pubitemid 20136689)
8. Le Cabec V, Cols C, Maridonneau-Parini I. Nonopsonic phagocytosis of zymosan and Mycobacterium kansasii by CR3 (CD11b/CD18) involves distinct molecular determinants and is or is not coupled with NADPH oxidase activation. Infect Immun 2000; 68(8):4736-45. (Pubitemid 30497748)
9. Sturgill-Koszycki S, Haddix PL, Russell DG. The interaction between Mycobacterium and the macrophage analyzed by two-dimensional polyacrylamide gel electrophoresis. Electrophoresis 1997; 18(14):2558-65. (Pubitemid 28133337)
10. Schorey JS, Carroll MC, Brown EJ. A macrophage invasion mechanism of pathogenic mycobacteria. Science 1997; 277(5329):1091-3. (Pubitemid 27371629)
11. Hu C, Mayada-Norton T, Tanaka K et al. Mycobacterium tuberculosis infection in complement receptor 3-deficient mice. J Immunol 2000; 165(5):2596-602. (Pubitemid 30660706)
12. Schlesinger LS, Kaufman TM, Iyer S et al. Differences in mannose receptor-mediated uptake of lipoarabinomannan from virulent and attenuated strains of Mycobacterium tuberculosis by human macrophages. J Immunol 1996; 157(10):4568-75. (Pubitemid 126449378)
13. Kang PB, Azad AK, Torrelles JB et al. The human macrophage mannose receptor directs Mycobacterium tuberculosis lipoarabinomannan-mediated phagosome biogenesis. J Exp Med 2005; 202(7):987-99. (Pubitemid 41396898)
14. Schlesinger LS. Macrophage phagocytosis of virulent but not attenuated strains of Mycobacterium tuberculosis is mediated by mannose receptors in addition to complement receptors. J Immunol 1993; 150(7):2920-30. (Pubitemid 23127541)
15. Peterson PK, Gekker G, Hu S et al. CD14 receptor-mediated uptake of nonopsonized Mycobacterium tuberculosis by human microglia. Infect Immun 1995; 63(4):1598-602.
16. Khanna M. Srivastava LM. Release of superoxide anion from activated mouse peritoneal macrophages during Mycobacterium tuberculosis infection. Indian J Exp Biol 1996; 34(5):468-71. (Pubitemid 126509273)
17. Shams H, Wizel B, Lakey DL et al. The CD14 receptor does not mediate entry of Mycobacterium tuberculosis into human mononuclear phagocyres. FEMS Immunol Med Microbiol 2003; 36(1-2):63-9. (Pubitemid 36515085)
18. Zimmerli S, Edwards S. Ernst JD. Selective receptor blockade during phagocyrosis does not alter the survival and growth of Mycobacterium tuberculosis in human macrophages. Am J Respir Cell Mol Biol 1996; 15(6):760-70. (Pubitemid 126441449)
19. Armstrong JA. Hart PD. Phagosome-lysosome interactions in cultured macrophages infected with virulent tubercle bacilli. Reversal of the usual nonfusion pattern and observations on bacterial survival. J Exp Med 1975; 142(1):1-16.
20. Downing JF, Pasula R, Wright JR et al. Surfactant protein a promotes attachment of Mycobacterium tuberculosis to alveolar macrophages during infection with human immunodeficiency virus. Proc Natl Acad Sci USA 1995; 92(11):4848-52.
21. Gaynor CD, McCormack FX. Voelker DR et al. Pulmonary surfactant protein A mediates enhanced phagocytosis of Mycobacterium tuberculosis by a direct interaction with human mactophages. J Immunol 1995; 155(11):5343-51.
22. Pasula R, Wright JR. Kachel DL et al. Surfactant protein A suppresses reactive nitrogen intermediates by alveolar macrophages in response to Mycobacterium tuberculosis. J Clin Invest 1999; 103(4):483-90. (Pubitemid 29094048)
23. Tenner AJ. Robinson SL, Borchelt J. Wright JR et al. Human pulmonary surfactant protein (SP-A). a protein structurally homologous to Clq. can enhance FcR- and CR1-mediated phagocytosis. J Biol Chem 1989; 264(23):13923-8. (Pubitemid 19198488)
24. Beharka AA, Gaynor CD, Kang BK et al. Pulmonary surfactant protein A up-regulates activity of the mannose receptor, a pattern recognition receptor expressed on human macrophages. J Immunol 2002; 169(7):3565-73.
25. Ferguson JS, Voelker DR. McCormack FX et al. Surfactant protein D binds to Mycobacterium tuberculosis bacilli and lipoarabinomannan via carbohydrate-lectin interactions resulting in reduced phagocytosis of the bacteria by macrophages. J Immunol 1999; 163(1):312-21. (Pubitemid 29295855)
26. Gatfield J. Pieters J. Essential role for cholesterol in entry of mycobacteria into macrophages. Science 2000; 288(5471):1647-50. (Pubitemid 30387431)
27. Armstrong JA. Hart PD. Response of cultwed macrophages to Mycobacterium tuberculosis. with observations on fusion of Iysosomes with phagosomes. J Exp Med 1971; 134(3 Pt 1):713-40.
28. Stwgill-Koszycki S, Schaible UE, Russell DG. Mycobacterium-containing phagosomes are accessible to early endosomes and reflect a transitional state in normal phagosome biogenesis. EMBO J 1996; 15(24):6960-8. (Pubitemid 27023267)
29. Schaible UE. Collins HL, Priem F et al. Correction of the iron overload defect in beta-2-mictoglobulin knockout mice by lactoferrin abolishes their increased susceptibility to tuberculosis. J Exp Med 2002; 196(11):1507-13. (Pubitemid 35424944)
30. Russell DG, Dant J, Sturgill-Koszycki S. Mycobacterium avium- and Mycobacterium tuberculosis-containing vacuoles are dynamic, fusion-competent vesicles that are accessible to glycosphingolipids from the host cell plasmalemma. J Immunol 1996; 156(12):4764-73. (Pubitemid 26174461)
31. Clemens DL, Horwitz MA. The Mycobacterium tuberculosis phagosome interacts with early endosomes and is accessible to exogenously administered transferrin. J Exp Med 1996; 184(4):1349-55. (Pubitemid 26354691)
32. Stwgill-Koszycki S. Schlesinger PH, Chakraborty P et al. Lack of acidification in Mycobacterium phagosomes produced by exclusion of the vesicular proton-ATPase. Science 1994; 263(5147):678-81.
33. Via LE. Deretic D, Ulmer RJ et al. Arrest of mycobacterial phagosome maturation is caused by a block in vesicle fusion berween stages controlled by rab5 and rab7. J Biol Chem 1997; 272(20): 13326-31. (Pubitemid 27216764)
34. Rink J, Ghigo E, Kalaidzidis Y, Zerial M. Rab conversion as a mechanism of progression from early to late endosomes. Cell 2005; 122(5):735-49. (Pubitemid 41242638)
35. Fratti RA. Backer JM. Gruenberg J et al. Role of phosphatidylinositol 3-kinase and Rab5 effectors in phagosomal biogenesis and mycobacterial phagosome maturation arrest. J Cell Biol 2001; 154(3):631-44. (Pubitemid 34286167)
36. Deretic V, Vergne I, Chua J et al. Endosomal membrane traffic: convergence point targeted by Mycobacterium tuberculosis and HIV. Cell Microbiol 2004; 6(11):999-1009. (Pubitemid 39386678)
37. Kusner DJ. Mechanisms of mycobacterial persistence in tuberculosis. Clin Immunol 2005; 114(3):239-47. (Pubitemid 40255129)
38. Vergne I, Chua J, Deretic V. Tuberculosis toxin blocking phagosome maturation inhibits a novel Ca2+/calmodulin-PI3K hVPS34 cascade. J Exp Med 2003; 198(4):653-9. (Pubitemid 37040399)
39. Thompson CR, Iyer SS, Melrose N et al. Sphingosine kinase 1 (SK1) is recruited to nascent phagosomes in human macrophages: inhibition of SK1 translocation by Mycobacterium tuberculosis. J Immunol 2005; 174(6):3551-61. (Pubitemid 40354064)
40. Anes E, Kiihnel MP, Bos E et al. Selected lipids activate phagosome actin assembly and maturation resulting in killing of pathogenic mycobacteria. Nat Cell Biol 2003; 5(9):793-802. (Pubitemid 37087167)
41. Kelley VA, Schorey JS. Mycobacterium's arrest of phagosome maturation in macrophages requires Rab5 activity and accessibility to iron. Mol Biol Cell 2003; 14(8):3366-77. (Pubitemid 37013133)
42. Walburger A, Koul A, Ferrari G et al. Protein kinase G from pathogenic mycobacteria promotes survival within macrophages. Science 2004; 304(5678):1800-4. (Pubitemid 38787896)
43. Tailleux L, Neyrolles O, Honore-Bouakline S et al. Constrained intracellular survival of Mycobacterium tuberculosis in human dendritic cells. J Immunol 2003; 170(4):1939-48. (Pubitemid 36197413)
44. Brightbill HD, Libraty DH, Krutzik SR et al. Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science 1999; 285(5428):732-6.
45. Pecora NO, Gehring AJ, Canaday DH et al. Mycobacterium tuberculosis LprA is a lipoprotein agonist ofTLR2 that regulates innate immunity and APC function. J Immunol 2006; 177(1):422-9. (Pubitemid 43939154)
46. Gehring AJ, Dobos KM, Belisle JT et al. Mycobacterium tuberculosis LprG (Rv1411c): a novel TLR-2 ligand that inhibits human macrophage class II MHC antigen processing. J Immunol 2004; 173(4):2660-8. (Pubitemid 39063126)
47. Abel B, Thieblemont N, Quesniaux VJ et al. Toll-like receptor 4 expression is required to control chronic Mycobacterium tuberculosis infection in mice. J Immunol 2002; 169(6):3155-62. (Pubitemid 35013161)
48. Jung SB, Yang CS, Lee JS et al. The mycobacterial 38-kilodalton g1ycolipoprotein antigen activates the mitogen-activated protein kinase pathway and release of proinflarnmatoty cyrokines through Toll-like receptors 2 and 4 in human monocyres. Infect Immun 2006; 74(5):2686-96.
49. Doz E, Rose S, Nigou J. et al. Acylation determines the toll-like receptor (TLR)-dependent positive versus TLR2-, mannose receptor-, and SIGNRI-independent negative regulation of pro-inflammatoty cyrokines by mycobacreriallipomannan. J Biol Chem 2007; 282(36):26014-25. (Pubitemid 47443801)
50. Hemmi H, Takeuchi O, Kawai T et al. A Toll-like receptor recognizes bacterial DNA. Nature 2000; 408(6813):740-5. (Pubitemid 32015992)
51. Tjarnlund A, Guirado E, Julian E et al. Determinant role for Toll-like receptor signalling in acute mycobacterial infection in the respiratory tract. Microbes Infect 2006; 8(7): 1790-800. (Pubitemid 44128881)
52. Underhill OM, Ozinsky A, Smith KD, Aderem A. Toll-like receptor-2 mediates mycobacteria-induced proinflarnmatoty signaling in rnacrophages. Proc Natl Acad Sci USA 1999; 96(25):14459-63. (Pubitemid 30000672)
53. Jang S, Uematsu S, Akira S, Salgarne P. IL-6 and IL-10 induction from dendritic cells in response to Mycobacterium tuberculosis is predominantly dependent on TLR2-mediated recognition. J Immunol 2004; 173(5):3392-7. (Pubitemid 39142049)
54. Salgarne P. Host innate and Th1 responses and the bacterial factors that control Mycobacterium tuberculosis infection. Curr Opin Immunol 2005; 17(4):374-80.
55. Reiling N, Holscher C, Fehrenbach A et al. Cutting edge: Toll-like receptor (TLR)2- and TLR4-mediated pathogen recognition in resistance to airborne infection with Mycobacterium tuberculosis. J Immunol 2002; 169(7):3480-4.
56. Branger J, Leemans JC, Florquin S et al. Toll-like receptor 4 plays a protective role in pulmonary tuberculosis in mice. Int Immunol 2004; 16(3):509-16. (Pubitemid 38313159)
57. Baflca A, Scanga CA, Feng CG et al. TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis. J Exp Med 2005; 202(12):1715-24. (Pubitemid 41815877)
58. Esraquier J, Idziorek T, Zou Wet al. T helper type 1/T helper type 2 cyrokines and T cell death: preventive effect of interleukin 12 on activation-induced and CD95 (FAS/APO-l)-mediated apoptosis of CD4+ T cells from human immunodeficiency virus-infected persons. J Exp Med 1995; 182(6): 1759-67.
59. Ladel CH, Szalay G, Riederl O et al. Interleukin-12 secretion by Mycobacterium tuberculosis-infected macrophages. Infect Immun 1997; 65(5):1936-8. (Pubitemid 27193622)
60. Giacomini E, Iona E, Ferroni L et al. Infection of human macrophages and dendritic cells with Mycobacterium tuberculosis induces a differential cyrokine gene expression that modulates T cell response. J Immunol 2001; 166(12):7033-41. (Pubitemid 32525572)
61. Flynn JL, Goldstein MM, Triebold KJ et al. IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection. J Immunol 1995; 155(5):2515-24.
62. Feng CG, Jankovic O, Kullberg M et al. Maintenance of pulmonary Th1 effector function in chronic tuberculosis requires persistent IL-12 production. J Immunol 2005; 174(7):4185-92. (Pubitemid 40395997)
63. Wozniak TM, Ryan AA, Britton WJ. Interleukin-23 restores immunity to Mycobacterium tuberculosis infection in IL-12p40-deficient mice and is not required for the development of IL-17-secreting T cell responses. J Immunol 2006; 177(12):8684-92. (Pubitemid 44893833)
64. Takeda K, Akira S. Toll-like receptors. Curr Protoc Immunol 2007; Chapter 14:Unit 14 12.
65. Hölscher C, Hölscher A, Rückerl D et al. The IL-27 receptor chain WSX-1 differentially regulates antibacterial immunity and survival during experimental tuberculosis. J Immunol 2005: 174(6):3534-44. (Pubitemid 40354062)
66. Pearl JE, Khader SA, Solache A et al. IL-27 signaling compromises control of bacterial growth in mycobacteria-infected mice. J Immunol 2004: 173(12):7490-6. (Pubitemid 39628189)
67. Flynn JL, Goldstein MM, Chan J et al. Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 1995: 2(6):561-72.
68. Flynn JL Immunology of tuberculosis and implications in vaccine development. Tuberculosis (Edinb) 2004: 84(1-2):93-101. (Pubitemid 38087953)
69. Keane J, Balcewicz-Sablinska MK, Remold HG et al. Infection by Mycobacterium tuberculosis promotes human alveolar macrophage apoptosis. Infect Immun 1997: 65(1):298-304. (Pubitemid 27008937)
70. Winau F, Weber S, Sad S et al. Apoptotic vesicles crossprime CD8 T cells and protect against tuberculosis. Immunity 2006: 24(1):105-17. (Pubitemid 43077204)
71. Balcewicz-Sablinska MK, Keane J, Kornfeld H, Remold HG. Pathogenic Mycobacterium tuberculosis evades apoptosis of host macrophages by release of TNF-R2, resulting in inactivation of TNF-alpha. J Immunol 1998: 161(5):2636-41. (Pubitemid 28397084)
72. Boussiotis VA, Tsai EY, Yunis EJ et al. IL-10-producing T cells suppress immune responses in anergic tuberculosis patients. J Clin Invest 2000: 105(9):1317-25. (Pubitemid 30266085)
73. Bhatt K, Salgame P. Host innate immune response to Mycobacterium tuberculosis. J Clin Immunol 2007: 27(4):347-62. (Pubitemid 46906653)
74. Peters W, Scott HM, Chambers HF et al. Chemokine receptor 2 serves an early and essential role in resistance to Mycobacterium tuberculosis. Proc Nad Acad Sci USA 2001: 98(14):7958-63. (Pubitemid 32642669)
75. Scott HM, Flynn JL. Mycobacterium tuberculosis in chemokine receptor 2-deficient mice: influence of dose on disease progression. Infect Immun 2002: 70(11):5946-54. (Pubitemid 35192682)
76. Algood HM, Flynn JL. CCR5-deficient mice control Mycobacterium tuberculosis infection despite increased pulmonary lymphocytic infiltration. J Immunol 2004; 173(5):3287-96. (Pubitemid 39142037)
77. FlolO RA, MacAty PA, Boname JM et al. Dendritic cell stimulation by mycobacterial Hsp70 is mediated through CCRS. Science 2006: 314(5798):454-8. (Pubitemid 44628964)
78. Bhatt K, Hickman SP, Salgame P. Cutting edge: a new approach to modeling early lung immunity in murine tuberculosis. J Immunol 2004: 172(5):2748-51. (Pubitemid 38263657)
79. Makino M, Maeda Y, Mukai T et al. Impaired maturation and function of dendritic cells by mycobacteria through IL-1beta. Eur J Immunol 2006: 36(6):1443-52. (Pubitemid 43942134)
80. Demangel C, Brodin P, Cockie PJ et al. Cell envelope protein PPE68 contributes to Mycobacterium tuberculosis RD1 immunogenicity independendy of a 10-kilodalton culture fLltrate protein and ESAT-6. Infect Immun 2004: 72(4):2170-6. (Pubitemid 38419931)